Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Condition: Breast Cancer Interventions: Drug: Dalcelli、Exemestane、Gosserine; Drug: Docetaxel for injection、Epirubicin hydrochloride for injection、Cyclophosphamide for injection Sponsor: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials